CELC Stock Analysis: Buy, Sell, or Hold?

CELC - Celcuity Inc. Common Stock

SERVICES-MEDICAL LABORATORIES
$93.53
2.96 (3.27%) ▲
5d: +1.66%
30d: +5.88%
90d: -34.38%
WAIT
LOW Confidence
Protect Your CELC Gains
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 13, 2026 0d
Smart Money Distribution

Options positioning is turning defensive after a sharp run-up - a pattern consistent with institutional profit-taking. View Scanner →

Signal fired Aug 14, 2026 at $92.00 · last confirmed Aug 21, 2026

Strength: 6.0/10

Get Alerted When CELC Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
â„šī¸ NEUTRAL: CELC is fairly priced but lacks strong directional signals. At 0% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.
See Forward Earnings Fair Value & Price Prediction →

In-depth Analysis How we analyze

Valuation Analysis: CELC is currently trading at $93.53, which is considered slightly high relative to its 30-day fair value range of $84.89 to $95.40. From a valuation perspective, the stock is trading at a discount (Forward PE: -1169.1) compared to its historical average (125.4). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.

Technical Outlook: Technically, CELC is in a strong downtrend. The price is approaching resistance at $96.00. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.3% recently.

Market Sentiment: The stock scores a mixed 58/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $161.09 (+72.2%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position SLIGHTLY HIGH
Historical Trading Range $84.89 - $95.40
Company Quality Score 46/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 79.6%

Protect Your Profits

Holding CELC? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

  • BULLISH: Options cheap (IV 0th percentile)
  • NEUTRAL: Mixed technical signals (58/100)
  • BULLISH: High volume confirmation
  • BULLISH: Strong upward momentum (+3.3%)
  • BULLISH: Trading 72.2% below Wall St target ($161.09)
  • BULLISH: Market expects only 0% annual growth - appears undervalued
  • WARNING: Composite score 46/100 in the bottom quintile — this cohort historically lags the market

Trading Range Analysis

30-Day Trading Range $84.89 - $95.40
Current vs Trading Range SLIGHTLY HIGH
Expected Move (7 Days) Âą$7.46 (8.0%)

Support & Resistance Levels

Support Level $83.04
Resistance Level $96.01
Current Trend Strong Downtrend
Technical data as of Aug 21, 2026

Fundamental Context

Forward P/E (Next Year Est.) -1169.12
Wall Street Target $161.09 (+72.2%)
PE vs Historical -1169.1 vs 125.4 CHEAP
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: August 22, 2026 6:58 PM ET
Data refreshes hourly during market hours. Next update: 7:58 PM
đŸ”Ĩ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Richard E Buller SELL 3000 shares 2026-03-31

Unlock Insider Activity

See real-time buying/selling by company executives for CELC.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
ALNY
Alnylam Pharmaceuticals â€Ļ
STRONG BUY
30 analysts
$372 42 HOLD
ONC
BeiGene, Ltd.
STRONG BUY
24 analysts
$433 27 SELL
VRTX
Vertex Pharmaceuticals Iâ€Ļ
BUY
34 analysts
$563 30 SELL
ASND
Ascendis Pharma AS
STRONG BUY
16 analysts
$309 51 HOLD
APLS
Apellis Pharmaceuticals â€Ļ
BUY
22 analysts
$41 50 HOLD

Advanced CELC Option Strategies

Professional options setups generated by AI based on today's CELC price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for CELC

CELC Technical Chart CELC Price Prediction CELC Earnings Date CELC Investment Advisor CELC Fair Price Analyzer CELC Options Advisor CELC Options Chain CELC Options Analysis CELC Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals